TrialNature medicine2021

Inhibition of phosphodiesterase-4D in adults with fragile X syndrome: a randomized, placebo-controlled, phase 2 clinical trial.

Elizabeth M Berry-Kravis et al.PubMed ↗Publisher ↗

No numbers read from the abstract.